Facebook
Instagram
TikTok
X
Financial Services
Technology
Energy
Environment
Education
Search
Facebook
Instagram
Linkedin
X
My account
Get into your account.
Login
Register
Got a tip? Call (777) 625-7647
Subscribe
Select a plan
Choose a plan from below, subscribe, and get access to our exclusive articles!
Monthly plan
$
13
$
0
billed monthly
Choose plan
Yearly plan
$
100
$
0
billed yearly
Choose plan
All plans include
Donec sagittis elementum
Cras tempor massa
Mauris eget nulla ut
Maecenas nec mollis
Donec feugiat rhoncus
Sed tristique laoreet
Fusce luctus quis urna
In eu nulla vehicula
Duis eu luctus metus
Maecenas consectetur
Vivamus mauris purus
Aenean neque ipsum
Search
Search for an article
Type in your search query...
Financial Services
Technology
Energy
Environment
Education
Home
Tags
F&B
F&B
SGX-LISTED COMPANIES
Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs
Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
June 18, 2026
Pharmaceutical
AstraZeneca invests US$20M to curb Malaysia chronic disease burden
AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
June 16, 2026
SGX-LISTED COMPANIES
How Envictus Offset Middle East Headwinds In 1H FY2026
Chickens Hunker Down as Dairy Takes Flight How does a geopolitical flare-up in the Persian...
May 8, 2026
SGX-LISTED COMPANIES
ABR Holdings Makes A $427 Million Pivot In FY2025
https://open.spotify.com/episode/0ETGmmjTvjwcdR3IXscy7U?si=ff4f99c684184cc3 From Sundaes to Skyscrapers: Can ABR Group’s $427 Million Pivot Hedge Against a Squeezed...
February 25, 2026
SGX-LISTED COMPANIES
From Superfoods To Senior Care – Autagco Q1 FY2026
The High-Stakes Gamble of a Singapore Mainstay Introduction: The "Pivot or Perish" Reality In the unforgiving...
January 28, 2026
SGX-LISTED COMPANIES
How Del Monte Delivered A 700% Profit Surge In Q2 FY2026
How Del Monte Pacific Engineered a 737% Profit Surge After Axing Its U.S. Business Sometimes,...
December 10, 2025
SGX-LISTED COMPANIES
JUMBO Group FY2025 Profit Plunge – What Triggered The Dramatic Cost Hike?
Jumbo Group's Profits Plunged 37%. So Why Did They Just Announce a Special Dividend? For...
November 26, 2025
SGX-LISTED COMPANIES
See How Kimly Built Organizational Resilience In FY2025
More Than Just Kopi: 5 Surprising Strategies Fueling Singapore's Coffee Shop Giant Introduction: The Coffee...
November 25, 2025
SGX-LISTED COMPANIES
The FY2025 Profit Puzzle At Envictus International Revealed
Envictus Grew Its Revenue by 8.4%—So Why Did Its Profits Plunge by 40%? 5...
November 25, 2025
SGX-LISTED COMPANIES
How Each Of Yoma Strategic’s Core Segments Drove Its 1H2026 Performance
4 Surprising Stories from Yoma Strategic's Latest Earnings Introduction: This post aims to distill the most...
November 11, 2025
SGX-LISTED COMPANIES
V2Y Corporation Interim Financial Statements 1H 2025
This financial period marks a significant shift for V2Y Corporation Ltd. The company has...
September 12, 2025
SGX-LISTED COMPANIES
Del Monte Pacific: Strong Q1 FY2026 Growth
Del Monte Pacific Limited reports a strong start to the fiscal year, with improved...
September 10, 2025
SGX-LISTED COMPANIES
Sakae Holdings: Financial Results 30 June 2025
Sakae Holdings LTD navigated a challenging F&B landscape, facing increased operating costs and cautious...
August 29, 2025
Latest articles
SGX-LISTED COMPANIES
Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs
Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
June 18, 2026
Pharmaceutical
AstraZeneca invests US$20M to curb Malaysia chronic disease burden
AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
June 16, 2026
Pharmaceutical
AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths
AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
June 16, 2026
Pharmaceutical
AstraZeneca deploys AI to cut drug timelines by 30% and boost survival
AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...
June 16, 2026